Patents for C07K 19 - Hybrid peptides (29,428) |
---|
01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
01/17/2002 | WO2002004522A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
01/17/2002 | WO2001047543A3 Activation and inhibition of the immune system |
01/17/2002 | WO2001046228A3 Nucleic acid vaccination |
01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
01/17/2002 | WO2001032696A3 Traf family proteins |
01/17/2002 | WO2001021656A3 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
01/17/2002 | US20020006903 Genetic engineering |
01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
01/17/2002 | CA2658217A1 Expression system |
01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
01/17/2002 | CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
01/17/2002 | CA2414272A1 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
01/17/2002 | CA2413045A1 Expression system |
01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
01/16/2002 | EP1171602A1 Anti-angiogenic intestinal peptides, zdint5 |
01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
01/16/2002 | EP1171592A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain |
01/16/2002 | EP1171098A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
01/16/2002 | EP0515516B1 Methods for identifying heterofunctional fusion proteins |
01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
01/15/2002 | US6338952 Stress proteins and uses therefor |
01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
01/14/2002 | CA2352036A1 Crystal structure of antibiotics bound to the 30s ribosome and its use |
01/10/2002 | WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
01/10/2002 | WO2002002751A2 Alteration of cell membrane |
01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
01/10/2002 | WO2002002633A2 Transporters and ion channels |
01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
01/10/2002 | WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
01/10/2002 | WO2001018050A3 T2r taste receptor family |
01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
01/10/2002 | CA2413128A1 Transporters and ion channels |
01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
01/10/2002 | CA2412845A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |
01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
01/08/2002 | CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
01/03/2002 | WO2002000991A1 Method for improving transfection efficiency |
01/03/2002 | WO2002000892A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
01/03/2002 | WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
01/03/2002 | WO2002000880A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
01/03/2002 | WO2002000867A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
01/03/2002 | WO2002000724A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
01/03/2002 | WO2002000721A2 Cytokine receptor zcytor17 |
01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
01/03/2002 | WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer |
01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
01/03/2002 | WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them |